These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 15140328

  • 1. Left ventricular hypertrophy in hypertensive patients in Indian primary care: prevalence and effect of treatment with sustained release indapamide.
    Lokhandwala Y, Damle A.
    Curr Med Res Opin; 2004 May; 20(5):639-44. PubMed ID: 15140328
    [Abstract] [Full Text] [Related]

  • 2. Left ventricular hypertrophy regression: the LIVE trial.
    Sheridan DJ.
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):541-3. PubMed ID: 12497780
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of indapamide 1.5 mg, sustained release, in the lowering of systolic blood pressure.
    London GM.
    J Hum Hypertens; 2004 Dec; 18 Suppl 2():S9-S14. PubMed ID: 15592572
    [Abstract] [Full Text] [Related]

  • 4. Clinical role of Natrilix SR in the treatment of at-risk hypertensive patients.
    Ambrosioni E, Veronesi M.
    J Hypertens Suppl; 2003 Mar; 21(1):S13-7. PubMed ID: 12769162
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Trends in hypertension control and left ventricular hypertrophy over three years.
    Cuspidi C, Michey I, Meani S, Severgnini B, Fusi V, Salerno M, Valerio C, Magrini F, Zanchetti A.
    Ital Heart J; 2002 Sep; 3(9):514-9. PubMed ID: 12407847
    [Abstract] [Full Text] [Related]

  • 10. Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.
    Okin PM, Devereux RB, Gerdts E, Snapinn SM, Harris KE, Jern S, Kjeldsen SE, Julius S, Edelman JM, Lindholm LH, Dahlöf B, LIFE Study Investigators.
    Circulation; 2006 Mar 28; 113(12):1588-96. PubMed ID: 16534012
    [Abstract] [Full Text] [Related]

  • 11. Further evidence for low-dose combinations in patients with left ventricular hypertrophy.
    Dahlöf B.
    J Hum Hypertens; 2005 Jun 28; 19 Suppl 1():S9-14. PubMed ID: 16075032
    [Abstract] [Full Text] [Related]

  • 12. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
    Ruilope LM, Schmieder RE.
    Am J Hypertens; 2008 May 28; 21(5):500-8. PubMed ID: 18437140
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of left ventricular hypertrophy detected by Cornell voltage-duration product in a hypertensive population.
    Barrios V, Escobar C, Calderon A, Ribas L, Marti D, Asin E.
    Blood Press; 2008 May 28; 17(2):110-5. PubMed ID: 18568700
    [Abstract] [Full Text] [Related]

  • 14. [Therapeutic benefit of a low dose of indapamide: results of a double-blind against placebo European controlled study].
    Asmar R, Guez D, Malbezin M, Brault Y, de Cordoue A, Barrandon S, Bruxelles MC, Chastang C.
    Arch Mal Coeur Vaiss; 1995 Aug 28; 88(8):1083-7. PubMed ID: 8572850
    [Abstract] [Full Text] [Related]

  • 15. [Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study].
    Lozano JV, Redón J, Cea-Calvo L, Fernández-Pérez C, Navarro J, Bonet A, González-Esteban J.
    Rev Esp Cardiol; 2006 Feb 28; 59(2):136-42. PubMed ID: 16540035
    [Abstract] [Full Text] [Related]

  • 16. Left ventricular hypertrophy and heart failure in women.
    Agabiti-Rosei E, Muiesan ML.
    J Hypertens Suppl; 2002 May 28; 20(2):S34-8. PubMed ID: 12183849
    [Abstract] [Full Text] [Related]

  • 17. Ventricular arrhythmias in hypertension: in which patients do they occur?
    Mayet J, Shahi M, Poulter NR, Sever PS, Thom SA, Foale RA.
    J Hypertens; 1995 Feb 28; 13(2):269-76. PubMed ID: 7615959
    [Abstract] [Full Text] [Related]

  • 18. An overview of the pharmacology and clinical efficacy of indapamide sustained release.
    Sassard J, Bataillard A, McIntyre H.
    Fundam Clin Pharmacol; 2005 Dec 28; 19(6):637-45. PubMed ID: 16313275
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of left ventricular hypertrophy as assessed by electrocardiogram in treated hypertensive persons in general practice.
    van den Hoogen JP, van Kruijsdijk MC, van Ree JW, Mokkink HG, Thien T, van Weel C.
    J Hum Hypertens; 1993 Oct 28; 7(5):473-7. PubMed ID: 8263888
    [Abstract] [Full Text] [Related]

  • 20. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M, Noberasco G, Re M, Filippi A, Gallina AM, Weiss U, Cannavò R, Ravera G, Cricelli C, Deferrari G.
    Nephrol Dial Transplant; 2009 May 28; 24(5):1528-33. PubMed ID: 19073656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.